Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29143893
Publication Date : //

The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction Cancer.


Approximately 20% of patients with cancer of the stomach or gastro-oesophageal junction (GOJ) present with resectable disease. Long-term outcome after surgery alone in these patients is poor, and a combined treatment approach is the standard of care. The two approaches to managing patients with cancer of the GOJ are perioperative chemotherapy or preoperative chemoradiotherapy. Based upon the most recent evidence, patients treated with a perioperative approach and deemed suitable for a triplet regimen should be considered for pre- and post-operative FLOT (5-fluorouracil [5-FU], leucovorin, oxaliplatin and docetaxel) and those suitable for a doublet regimen should be considered for a fluoropyrimidine/platinum combination such as capecitabine and oxaliplatin. Alternatively, such patients may be considered for preoperative chemoradiotherapy according to the CROSS regimen. True gastric cancers may be treated with a perioperative approach or, as is commonly used in Asia, postoperative adjuvant chemotherapy.

Authors : Cartwright Elizabeth , Cunningham David ,

Related products :

Catalog number Product name Quantity
TOC TOC Gene tylosis with oesophageal cancer
5-81011 Human gastric smooth muscle cells (tumor), male, 70, gastric cancer vial
27-424 Altered expression of GBX2, part of the homeobox-containing human family of DNA-binding transcription factors, is associated with therapy failure and death in patients with multiple types of cancer. 0.1 mg
ISTMC-N Cancer Samples: Gastric Carcinoma Cancer Plasma Each
ISTMC-SER Cancer samples: Gastric Carcinoma Cancer Serum Each
GI_Stomach - STC481 Stomach cancer tissue array, 16 cases of gastric cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
29-034 ERGIon Channel2 possibly play role in transport between endoplasmic reticulum and Golgi. ERGIon Channel2 is downregulated in prostate cancer. ERGIon Channel2 may play an important role in the growth a 0.1 mg
ISTMC-SER-Each Gastric Carcinoma Cancer Serum Each
ISTMC-N-Each Gastric Carcinoma Cancer Plasma Each
ISTMC-SER-1ml Gastric Carcinoma Cancer Serum 1ml 1ml
CA7241-N-10 Gastric Cancer Antigen (CA 72_4) 10 KU
ISTMC-N-1ml Gastric Carcinoma Cancer Plasma 1ml 1ml
BMDEU1023 CA_19_9, Gastric & Pancreatic Cancer, ELISA Kit kit
BMDEU1024 CA_242, Gastric & Pancreatic Cancer, ELISA Kit kit
gen4346 NUCB2_HUMAN Gastric cancer antigen Zg4 ELISA tesk kit 1
28-036 PCGF4 regulates telomerase expression in MECs and plays a role in the development of human breast cancer. 0.05 mg
Y051456 Anti-Calpain-9 (nCL-4, GC36, down regulated in gastric cancer"); Domain-I Antibody large subunit"
Y051458 Anti-Calpain-9 (nCL-4, GC36, down regulated in gastric cancer"); Domain-II Antibody large subunit"
Y051459 Anti-Calpain-9 (nCL-4, GC36, down regulated in gastric cancer"); Domain-IV (EF-1) Antibody large subunit"
18-003-42791 Nucleobindin-2 - DNA-binding protein NEFA; Gastric cancer antigen Zg4 Polyclonal 0.1 mg Protein A
18-003-42790 Nucleobindin-2 - DNA-binding protein NEFA; Gastric cancer antigen Zg4 Polyclonal 0.1 mg Protein A
31-269 CLDN18 plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.CLDN18 belongs to the large claudin family of proteins, 0.05 mg
GI481 GI cancer (gastric, colon and rectal carcinoma) tissue array, 24 cases_48 cores
Y051459 Anti-Calpain-9 nCL-4 GC36 "down regulated in gastric cancer"; Domain-IV EF-1 large subunit antibody 250ug
Y051458 Anti-Calpain-9 nCL-4 GC36 "down regulated in gastric cancer"; Domain-II large subunit antibody 250ug


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur